The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.

The somatically acquired V600E mutation of the BRAF gene has been recently described as a molecular marker of hairy cell leukemia (HCL). We developed an allele-specific PCR for this mutation and studied 62 patients with HCL, 1 with HCL variant, 91 with splenic marginal zone lymphoma, 29 with Waldenström macroglobulinemia, and 57 with B-cell chronic lymphoproliferative disorders. The BRAF V600E mutation was detected in all HCL cases and in only 2 of the remaining 178 patients. These 2 subjects had B-cell chronic lymphoproliferative disorders that did not fulfill the diagnostic criteria for HCL. Despite the positive PCR finding, the mutation could not be detected by Sanger sequencing in these 2 cases, suggesting that it was associated with a small subclone. We conclude that the BRAF V600E mutation is present in all patients with HCL and that, in combination with clinical and morphologic features, represents a reliable molecular marker for this condition.

[1]  A. Rossi,et al.  A multicenter retrospective clinical study of CD5/CD10‐negative chronic B cell leukemias , 2008, American journal of hematology.

[2]  Katia Basso,et al.  Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1) , 2004, The Lancet.

[3]  F. Forconi,et al.  Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies. , 2005, Haematologica.

[4]  A. Pinchera,et al.  BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. , 2004, The Journal of clinical endocrinology and metabolism.

[5]  M. Piris,et al.  Evolving concepts in the pathogenesis of hairy-cell leukaemia , 2006, Nature Reviews Cancer.

[6]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[7]  A. Hall,et al.  Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia. , 2008, Cancer research.

[8]  G. Follows,et al.  High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies , 2011, British journal of haematology.

[9]  F. Ajchenbaum‐Cymbalista,et al.  Deciphering leukemic B-cell chronic lymphoproliferative disorders , 2006, Leukemia & lymphoma.

[10]  A. Pinchera,et al.  BRAFV599E Mutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid Carcinomas , 2004 .

[11]  M. Dimopoulos,et al.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. , 2003, Seminars in oncology.

[12]  B. Johansson,et al.  BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias , 2008, Leukemia.

[13]  R. Warnke,et al.  Splenic B‐Cell Marginal Zone Lymphoma , 2011 .

[14]  W. Hahn,et al.  Recurrent BRAF mutations in Langerhans cell histiocytosis. , 2010, Blood.

[15]  A. Salar,et al.  Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria , 2008, Leukemia.

[16]  J. Stockman,et al.  Distinct Sets of Genetic Alterations in Melanoma , 2007 .

[17]  S H Lee,et al.  BRAF mutations in non-Hodgkin's lymphoma , 2003, British Journal of Cancer.

[18]  A. Tefferi,et al.  BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.

[19]  S. Chugh,et al.  Hairy cell leukaemia. , 1985, Journal of the Indian Medical Association.